Login

M. Angokai

ORCID: 0000-0002-5995-5253
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5077298724
Research Areas
  • Lung Cancer Treatments and Mutations
  • PI3K/AKT/mTOR signaling in cancer
  • Pharmacological Effects and Toxicity Studies
  • Lung Cancer Research Studies
  • Pharmaceutical studies and practices
  • Cancer, Hypoxia, and Metabolism
  • Cancer Diagnosis and Treatment
  • Hormonal Regulation and Hypertension
  • Cancer Genomics and Diagnostics
  • Head and Neck Cancer Studies
  • Oral health in cancer treatment
  • RNA modifications and cancer
  • Adrenal and Paraganglionic Tumors
  • Childhood Cancer Survivors' Quality of Life
  • Biomedical Text Mining and Ontologies
  • Data Analysis and Archiving

La Ligue Contre le Cancer
 2024

Inserm
 2024

Université Paris-Saclay
 2024

Centre de recherche en Epidémiologie et Santé des Populations
 2024

Institut Gustave Roussy
 2013-2024

 Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
OPENALEX - Publications 
Éric Baudin B. Goichot Alfredo Berruti Julien Hadoux Salma Moalla and 42 more S. Laboureau Svenja Nölting Christelle De La Fouchardière Tina Kienitz Timo Deutschbein Stefania Zovato Laurence Amar Magalie Haissaguerre Henri Timmers Patricia Niccoli Antongiulio Faggiano M. Angokai Livia Lamartina Florina Luca Deborah Cosentini Stefanie Hahner Felix Beuschlein Marie Attard Matthieu Texier Martin Faßnacht Christine Do Cao Delphine Drui Françoise Borson‐Chazot Olivier Chabre Delphine Vezzosi Fréderic Castinetti Jérôme Bertherat Rossella Libé Anne‐Paule Gimenez‐Roqueplo J. Favier Marcus Quinkler Christian J. Strasburger Katrin Zopf Martín Reincke Matthias Kroiß Hanna Remde Michaela Haaf Carmina Teresa Fuß Ulrich Dischinger Graeme Eisenhofer Christina Pamporaki Anouk van Berkel

10.1016/s0140-6736(23)02554-0 article EN The Lancet 2024-02-22
 Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer
OPENALEX - Publications 
Éric Deutsch C. Le Péchoux Laurence Faivre Sofía Rivera Yungan Tao and 9 more Jean‐Pierre Pignon M. Angokai Rastilav Bahleda Désirèe Deandreis Eric Angevin C. Hennequin Benjamin Besse Antonin Lévy Jean‐Charles Soria

10.1093/annonc/mdv105 article EN publisher-specific-oa Annals of Oncology 2015-02-21
 Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients
OPENALEX - Publications 
Yungan Tao Anne Aupérin Christian Sire Michel Martin M. Saliou and 11 more É. Bardet Xu Sun Thierry Chatellier Clotilde Morand A. Cornely M. Angokai Alessia Di Rito Ketty Kichenin Pierre Blanchard Ida D’Onofrio Jean Bourhis

10.1016/j.ijrobp.2017.07.019 article EN International Journal of Radiation Oncology*Biology*Physics 2017-07-23
 Phase I Trial of RAD001 (Everolimus) in Combination with Radiotherapy in Non-Small Cell Lung Cancer
OPENALEX - Publications 
Éric Deutsch C. Lepéchoux Jean‐Pierre Pignon Yungan Tao Sofía Rivera and 7 more B. C. Bourgier M. Angokai Rastilav Bahleda K. Slimane Eric Angevin B.B. Besse Jean‐Charles Soria

10.1093/annonc/mdt042.13 article EN publisher-specific-oa Annals of Oncology 2013-03-01
 Outil de RElance et Suivi des DOnnées Cliniques (ORESDOC)
OPENALEX - Publications 
Anthony Mangin Nadir Cheurfa M. Angokai P. Jan S. Maalem and 3 more Émilie Lanoy Dominique Schwob G. Goma

10.1016/j.respe.2017.03.013 article FR Revue d Épidémiologie et de Santé Publique 2017-04-28
Coming Soon ...